In a filing, Immuneering Corp revealed its 10% Owner Cormorant Asset Management, LP unloaded Company’s shares for reported $1.16 million on Apr 01 ’24. In the deal valued at $2.90 per share,400,000 shares were sold. As a result of this transaction, Cormorant Asset Management, LP now holds 2,895,273 shares worth roughly $5.53 million.
Then, Feinberg Peter bought 25,000 shares, generating $63,713 in total proceeds. Upon buying the shares at $2.55, the Director now owns 111,766 shares.
Before that, Brakewood Harold Eugene bought 3,900 shares. Immuneering Corp shares valued at $10,015 were divested by the Chief Business Officer at a price of $2.57 per share. As a result of the transaction, Brakewood Harold Eugene now holds 3,900 shares, worth roughly $7449.0.
Needham reiterated its Immuneering Corp [IMRX] rating to a Buy in a research note published on March 15, 2024; the price target was $15. A number of analysts have revised their coverage, including TD Cowen’s analysts, who decreased its forecast for the stock in mid March from “an Outperform” to “a Market perform”. Jefferies also remained covering IMRX and has decreased its forecast on March 15, 2024 with a “Hold” recommendation from previously “Buy” rating. Needham started covering the stock on December 01, 2023. It rated IMRX as “a Buy”.
Price Performance Review of IMRX
On Monday, Immuneering Corp [NASDAQ:IMRX] saw its stock fall -8.81% to $1.91. Over the last five days, the stock has lost -9.67%. Immuneering Corp shares have fallen nearly -73.95% since the year began. Nevertheless, the stocks have fallen -84.49% over the past one year. While a 52-week high of $14.29 was reached on 03/04/24, a 52-week low of $1.90 was recorded on 04/15/24. SMA at 50 days reached $4.56, while 200 days put it at $6.92. A total of 0.86 million shares were traded, compared to the trading of 0.72 million shares in the previous session.
Levels Of Support And Resistance For IMRX Stock
The 24-hour chart illustrates a support level at 1.84, which if violated will result in even more drops to 1.77. On the upside, there is a resistance level at 2.03. A further resistance level may holdings at 2.15. The Relative Strength Index (RSI) on the 14-day chart is 27.67, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.28, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 98.02%. Stochastics %K at 9.40% indicates the stock is a buying.
